These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 10427351

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
    Napier C, Stewart M, Melrose H, Hopkins B, McHarg A, Wallis R.
    Eur J Pharmacol; 1999 Mar 05; 368(2-3):259-68. PubMed ID: 10193663
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Rizatriptan: an update of its use in the management of migraine.
    Wellington K, Plosker GL.
    Drugs; 2002 Mar 05; 62(10):1539-74. PubMed ID: 12093318
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A triptan too far?
    Goadsby PJ.
    J Neurol Neurosurg Psychiatry; 1998 Feb 05; 64(2):143-7. PubMed ID: 9489518
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL, Keating GM.
    Drugs; 2006 Feb 05; 66(8):1129-49. PubMed ID: 16789799
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM.
    Cephalalgia; 2001 Feb 05; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Kayser V, Aubel B, Hamon M, Bourgoin S.
    Br J Pharmacol; 2002 Dec 05; 137(8):1287-97. PubMed ID: 12466238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.